Sign in →

Order Code 13ACT Coagulation Factor XIII (13) Activity Assay, Plasma


Ordering Guidance


Coagulation testing is highly complex, often requiring the performance and correlation of factor XIII activity with multiple assays and correlation with clinical information. For that reason, if indicated, consider ordering ALBLD / Bleeding Diathesis Profile, Limited, Plasma.



Specimen Required


Patient Preparation:

1. Fasting: 8 hours, preferred but not required

2. It is best to perform this study pre-plasma transfusion if possible. If patient has been recently transfused, wait at least 48 hours after transfusion before collecting the specimen.

3. Specimen should be collected prior to factor replacement therapy.

Collection Container/Tube: Light-blue top (3.2% sodium citrate)

Submission Container/Tube: Plastic vial

Specimen Volume: 1 mL Platelet-poor plasma

Collection Instructions:

1. For complete instructions, see Coagulation Guidelines for Specimen Handling and Processing.

2. Centrifuge, transfer all plasma into a plastic vial, and centrifuge plasma again.

3. Aliquot plasma into a plastic vial, leaving 0.25 mL in the bottom of centrifuged vial.

4. Freeze plasma immediately (no longer than 4 hours after collection) at -20° C or, ideally, -40° C or below.

Additional Information:

1. Double-centrifuged specimen is critical for accurate results.

2. Each coagulation assay requested should have its own vial.


Useful For

Measuring factor XIII activity

Method Name

Fluorescence-Based Enzyme Activity

Reporting Name

Factor XIII(13) Activity, P

Specimen Type

Plasma Na Cit

Specimen Minimum Volume

Platelet-poor plasma: 0.5 mL

Specimen Stability Information

Specimen Type Temperature Time
Plasma Na Cit Frozen 180 days

Reject Due To

Gross Hemolysis Reject
Gross Lipemia Reject
Gross Icterus Reject

Reference Values

≥55%

Method Description

Factor XIII (FXIII) is activated by thrombin in the presence of calcium. Activated FXIII then cleaves the sidechain carboxamide bond of the assay’s substrate and thereby releases the dark quencher (2,4-dinitrophenyl) linked to the cadaverine spacer. Subsequently, the increase of fluorescence results from the N-terminally attached fluorophore N-methyl-2-aminobenzoic acid. The fluorescent signal is proportional to the FXIII activity in the plasma sample.(Package insert: Technofluor FXIII Activity. Technoclone; 07/15/2020)

Day(s) Performed

Monday through Friday

Performing Laboratory

Mayo Clinic Laboratories in Rochester

CPT Code Information

85290

LOINC Code Information

Test ID Test Order Name Order LOINC Value
13ACT Factor XIII(13) Activity, P In Process

 

Result ID Test Result Name Result LOINC Value
623415 Factor XIII (13) Activity, P In Process

Forms

If not ordering electronically, complete, print, and send an Coagulation Test Request (T753) with the specimen.